SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-20-000016
Filing Date
2020-08-13
Accepted
2020-08-13 12:13:30
Documents
84
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20200630x10q.htm 10-Q 1686120
2 EX-31.1 veru-20200630xex31_1.htm EX-31.1 15608
3 EX-31.2 veru-20200630xex31_2.htm EX-31.2 15833
4 EX-32.1 veru-20200630xex32_1.htm EX-32.1 11665
  Complete submission text file 0000863894-20-000016.txt   8084334

Data Files

Seq Description Document Type Size
5 EX-101.INS veru-20200630.xml EX-101.INS 1881925
6 EX-101.SCH veru-20200630.xsd EX-101.SCH 70509
7 EX-101.CAL veru-20200630_cal.xml EX-101.CAL 98651
8 EX-101.DEF veru-20200630_def.xml EX-101.DEF 194630
9 EX-101.LAB veru-20200630_lab.xml EX-101.LAB 500850
10 EX-101.PRE veru-20200630_pre.xml EX-101.PRE 406913
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 201098189
SIC: 2834 Pharmaceutical Preparations